Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...

For horticulture businesses that operate delivery trucks, service vans, and fleet vehicles, driving risk is one of the most visible (and controllable) risks you manage.

KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027 KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ongoing, with data expected by mid-2027 Fast Track de ...

Amid what some call a new space race, the historic journey around the moon tested a spacecraft that had never before been ...

Flory Bidunga's $5M price tag highlights a growing trend: top college big men may earn more staying in school than entering the NBA Draft.

OT asset owners are being asked by regulators to attest to their post-quantum cryptographic readiness without the appropriate ...

It’s transfer portal season in college basketball and Ben McCollum is hunting for the perfect pieces for another NCAA ...

If you’ve recently been told something is “cap,” that someone has “no aura,” or that a situation is “cooked,” you are not alone. You may, in fact, be linguistically outmatched ...

Nevgold Corp. ("NevGold" or the "Company") (TSXV:NAU,OTC:NAUFF) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce ...

Detailed price information for Nervgen Pharma Corp (NGEN-X) from The Globe and Mail including charting and trades.